{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T12:12:11Z","timestamp":1760616731507,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"vor","delay-in-days":730,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.rmed.2013.07.011","type":"journal-article","created":{"date-parts":[[2013,8,15]],"date-time":"2013-08-15T10:07:38Z","timestamp":1376561258000},"page":"1939-1947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Factor analysis in predominantly severe COPD: Identification of disease heterogeneity by easily measurable characteristics"],"prefix":"10.1016","volume":"107","author":[{"given":"Dirkje S.","family":"Postma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio R.","family":"Anzueto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barry J.","family":"Make","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Similowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ollie","family":"\u00d6stlund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran S.","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Calverley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2013.07.011_bib1","doi-asserted-by":"crossref","first-page":"e442","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and\u00a0burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib2","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1016\/S0140-6736(12)61729-2","article-title":"Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Vos","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2013.07.011_bib3","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0140-6736(07)61380-4","article-title":"Global burden of COPD: risk factors, prevalence, and future trends","volume":"370","author":"Mannino","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2013.07.011_bib4","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1465-9921-11-122","article-title":"Characterisation of COPD heterogeneity in the ECLIPSE cohort","volume":"11","author":"Agusti","year":"2010","journal-title":"Respir Res"},{"year":"2011","series-title":"Global strategy for diagnosis, management, and prevention of COPD (2011 update)","author":"Global Initiative for Chronic Obstructive Lung Disease","key":"10.1016\/j.rmed.2013.07.011_bib5"},{"key":"10.1016\/j.rmed.2013.07.011_bib6","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1164\/rccm.201202-0223OC","article-title":"Spirometric predictors of lung function decline and mortality in early chronic obstructive pulmonary disease","volume":"185","author":"Drummond","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib7","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1146\/annurev.pathol.4.110807.092145","article-title":"The pathology of chronic obstructive pulmonary disease","volume":"4","author":"Hogg","year":"2009","journal-title":"Ann Rev Pathol"},{"key":"10.1016\/j.rmed.2013.07.011_bib8","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1056\/NEJMoa0909883","article-title":"Susceptibility to exacerbation in chronic obstructive pulmonary disease","volume":"363","author":"Hurst","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib9","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thorax.56.11.880","article-title":"Health status measurement in chronic obstructive pulmonary disease","volume":"56","author":"Jones","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2013.07.011_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes: the future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib11","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1183\/09031936.03.00027003","article-title":"Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease","volume":"22","author":"Calverley","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib12","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2165\/00003495-200969050-00004","article-title":"Efficacy and tolerability of budesonide\/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial","volume":"69","author":"Rennard","year":"2009","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2013.07.011_bib13","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1183\/09031936.03.00031402","article-title":"Efficacy and safety of budesonide\/formoterol in the management of chronic obstructive pulmonary disease","volume":"21","author":"Szafranski","year":"2003","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib14","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2165\/00003495-200868140-00004","article-title":"Efficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trial","volume":"68","author":"Tashkin","year":"2008","journal-title":"Drugs"},{"key":"10.1016\/j.rmed.2013.07.011_bib15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1164\/rccm.200904-0492OC","article-title":"Efficacy and tolerability of budesonide\/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease","volume":"180","author":"Welte","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1164\/ajrccm\/145.6.1321","article-title":"A self-complete measure of health status for chronic airflow limitation. The St. George's respiratory questionnaire","volume":"145","author":"Jones","year":"1992","journal-title":"Am Rev Respir Dis"},{"year":"1986","series-title":"Multivariate statistical methods: a primer","author":"Manly","key":"10.1016\/j.rmed.2013.07.011_bib17"},{"key":"10.1016\/j.rmed.2013.07.011_bib18","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1164\/rccm.201105-0831OC","article-title":"The progression of chronic obstructive pulmonary disease is heterogeneous","volume":"184","author":"Casanova","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib19","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.rmed.2005.03.019","article-title":"Proposal for a multidimensional staging system for chronic obstructive pulmonary disease","volume":"99","author":"Celli","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib20","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1183\/09031936.00175109","article-title":"Clinical COPD phenotypes: a novel approach using principal component and cluster analyses","volume":"36","author":"Burgel","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib21","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/thx.49.11.1109","article-title":"Influence of treatment on peak expiratory flow and its relation to airway hyperresponsiveness and symptoms. The Dutch CNSLD Study Group","volume":"49","author":"Kerstjens","year":"1994","journal-title":"Thorax"},{"key":"10.1016\/j.rmed.2013.07.011_bib22","doi-asserted-by":"crossref","first-page":"137S","DOI":"10.1378\/chest.91.6_Supplement.137S","article-title":"Diurnal rhythm of asthma","volume":"91","author":"Clark","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2013.07.011_bib23","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0091-6749(95)70011-0","article-title":"Inflammatory cell number and mediators in bronchoalveolar lavage fluid and peripheral blood in subjects with asthma with increased nocturnal airways narrowing","volume":"96","author":"Oosterhoff","year":"1995","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.rmed.2013.07.011_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1183\/09031936.00051110","article-title":"Symptom variability in patients with severe COPD: a pan-European cross-sectional study","volume":"37","author":"Kessler","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib25","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4104\/pcrj.2011.00041","article-title":"A new perspective on optimal care for patients with COPD","volume":"20","author":"Postma","year":"2011","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib26","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1001\/archinte.160.17.2653","article-title":"Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization","volume":"160","author":"Mapel","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rmed.2013.07.011_bib27","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1378\/chest.128.4.2099","article-title":"Patterns of comorbidities in newly diagnosed COPD and asthma in primary care","volume":"128","author":"Soriano","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2013.07.011_bib28","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1183\/09031936.00165409","article-title":"Sex-related differences in COPD in five Latin American cities: the PLATINO study","volume":"36","author":"Lopez Varela","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2013.07.011_bib29","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/02770900500371047","article-title":"Obesity is associated with bronchial hyper-responsiveness in women","volume":"42","author":"Sood","year":"2005","journal-title":"J Asthma"},{"key":"10.1016\/j.rmed.2013.07.011_bib30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N Engl J Med"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113002643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611113002643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:28:41Z","timestamp":1760614121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611113002643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0954611113002643"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2013.07.011","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factor analysis in predominantly severe COPD: Identification of disease heterogeneity by easily measurable characteristics","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2013.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}